التفاصيل البيبلوغرافية
| العنوان: |
Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2 |
| المؤلفون: |
Smith, Michael J.1, Teel, Louise D.1, Carvalho, Humberto M.1, Melton-Celsa, Angela R.1, O’Brien, Alison D. aobrien@usuhs.mil |
| المصدر: |
Vaccine. May2006, Vol. 24 Issue 19, p4122-4129. 8p. |
| مصطلحات موضوعية: |
*PREVENTIVE medicine, *VACCINATION, *TOXINS, *ENTEROBACTERIACEAE |
| مستخلص: |
Abstract: The hemolytic uremic syndrome is a life-threatening sequela that occurs after infection with Shiga toxin (Stx)-producing Escherichia coli (STEC) or Shigella dysenteriae type 1, and Stx is responsible for initiating this syndrome. An STEC isolate can express Stx1, Stx2, or both, but antisera to Stx1 and Stx2 are not cross-neutralizing. To produce a single vaccine candidate against both toxins, we created a genetic toxoid that contained the enzymatically-inactivated StxA2 subunit and the native StxB1 subunit. We found that mice immunized with this hybrid holotoxoid, developed neutralizing anti-Stx1 and anti-Stx2 antibodies and survived challenge with 10 lethal doses of either or both toxins. [Copyright &y& Elsevier] |
| قاعدة البيانات: |
Academic Search Index |
